Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Newer agents in antiplatelet therapy: a review.

Journal of blood medicine

Yeung J, Holinstat M.
PMID: 22792011
J Blood Med. 2012;3:33-42. doi: 10.2147/JBM.S25421. Epub 2012 Jun 25.

Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in pathophysiological conditions such as myocardial infarction, ischemia, and stroke. Although there has been significant advancement in antiplatelet therapeutic approaches, aspirin still remains the gold standard treatment in the...

Cite
Yeung J, Holinstat M. Newer agents in antiplatelet therapy: a review. J Blood Med. 2012;3:33-42doi: 10.2147/JBM.S25421.
Yeung, J., & Holinstat, M. (2012). Newer agents in antiplatelet therapy: a review. Journal of blood medicine, 333-42. https://doi.org/10.2147/JBM.S25421
Yeung, Jennifer, and Holinstat, Michael. "Newer agents in antiplatelet therapy: a review." Journal of blood medicine vol. 3 (2012): 33-42. doi: https://doi.org/10.2147/JBM.S25421
Yeung J, Holinstat M. Newer agents in antiplatelet therapy: a review. J Blood Med. 2012;3:33-42. doi: 10.2147/JBM.S25421. Epub 2012 Jun 25. PMID: 22792011; PMCID: PMC3393068.
Copy Download .nbib Format: NLM
Paxillin is an intrinsic negative regulator of platelet activation in mice.

Thrombosis journal

Sakata A, Ohmori T, Nishimura S, Suzuki H, Madoiwa S, Mimuro J, Kario K, Sakata Y.
PMID: 24383745
Thromb J. 2014 Jan 02;12(1):1. doi: 10.1186/1477-9560-12-1.

BACKGROUND: Paxillin is a LIM domain protein localized at integrin-mediated focal adhesions. Although paxillin is thought to modulate the functions of integrins, little is known about the contribution of paxillin to signaling pathways in platelets. Here, we studied the...

Cite
Sakata A, Ohmori T, Nishimura S, et al. Paxillin is an intrinsic negative regulator of platelet activation in mice. Thromb J. 2014;12(1):1doi: 10.1186/1477-9560-12-1.
Sakata, A., Ohmori, T., Nishimura, S., Suzuki, H., Madoiwa, S., Mimuro, J., Kario, K., & Sakata, Y. (2014). Paxillin is an intrinsic negative regulator of platelet activation in mice. Thrombosis journal, 12(1), 1. https://doi.org/10.1186/1477-9560-12-1
Sakata, Asuka, et al. "Paxillin is an intrinsic negative regulator of platelet activation in mice." Thrombosis journal vol. 12,1 (2014): 1. doi: https://doi.org/10.1186/1477-9560-12-1
Sakata A, Ohmori T, Nishimura S, Suzuki H, Madoiwa S, Mimuro J, Kario K, Sakata Y. Paxillin is an intrinsic negative regulator of platelet activation in mice. Thromb J. 2014 Jan 02;12(1):1. doi: 10.1186/1477-9560-12-1. PMID: 24383745; PMCID: PMC3904695.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries